
Medleods Pharmaceuticals Private Limited
About Medleods Pharmaceuticals Private Limited
Data last updated:
Medleods Pharmaceuticals Private Limited is a private limited company based in Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 29 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2018PTC315060.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Shankar Singh and Sonal Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B/401 Vora Township Bldg No C S No 88/111 Ghodblindar Village Mira Road, Maharashtra, India – 401107.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.6 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹10,436 (net margin -6.5%) and EBITDA of -₹10,436 (EBITDA margin -6.5%). Revenue has grown at a compounded annual rate (CAGR) of 120% over three years.
Company details
Contact details
Medleods Pharmaceuticals Private Limited's registered office is in Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB/401 Vora Township Bldg No C S No 88/111 Ghodblindar Village Mira Road, Maharashtra, India – 401107
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Medleods Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medleods Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medleods Pharmaceuticals Private Limited, buy the company report.
Financials of Medleods Pharmaceuticals Private Limited
FY 2024 filings availableMedleods Pharmaceuticals Private Limited reported revenue of ₹1.6 Lakh (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 120%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10,436 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,436 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.5% | ||||
| Net Profit Margin | -6.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medleods Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medleods Pharmaceuticals Private Limited
Medleods Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Shankar Singh | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
| Sonal Singh | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Medleods Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Absolute Biotech Private Limited | ₹1.61 Lakh (FY 2018) | Mandsaur, Madhya Pradesh, India | ||||
| Khusheal Pharmaceuticals Private Limited | ₹1.61 Lakh (FY 2025) | 246.0% | Thane, Maharashtra, India | |||
| Medleods Pharmaceuticals Private Limitedthis company | ₹1.6 Lakh (FY 2024) | -₹10,436 | -6.5% | -4.0% | Maharashtra, India | |
| Conclave Pharma Private Limited | ₹1.58 Lakh (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Paramba Pharmaceuticals Private Limited | ₹1.58 Lakh (FY 2024) | -8.0% | Bhardwaj Nagar, Mohan Eghu, Bihar, India |
To see the full peer comparison of Medleods Pharmaceuticals Private Limited, buy the company report.
Auditor
Medleods Pharmaceuticals Private Limited is audited by GUPTA HEMANT AND CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA HEMANT AND CO | FY 2020 | 031100N |
Shareholding
The shareholding of Medleods Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medleods Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medleods Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medleods Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medleods Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medleods Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ravi Shankar Singh was appointed as Director on 29 Sep 2018.
Frequently asked questions
Medleods Pharmaceuticals is an active private limited company based in Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 29 September 2018 (8+ years old) and is registered under CIN U24100MH2018PTC315060.
Medleods Pharmaceuticals has 2 current directors:
- Ravi Shankar Singh - Director
- Sonal Singh - Director
The latest financial statements of Medleods Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Medleods Pharmaceuticals is U24100MH2018PTC315060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medleods Pharmaceuticals was incorporated on 29 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medleods Pharmaceuticals by revenue are Absolute Biotech Private Limited, Khusheal Pharmaceuticals Private Limited, Conclave Pharma Private Limited, Paramba Pharmaceuticals Private Limited, all in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ravi Shankar Singh was appointed as Director on 29 Sep 2018. Sonal Singh was appointed as Director on 29 Sep 2018.
The registered office of Medleods Pharmaceuticals is at B401 Vora Township Bldg No C S No 88111 Ghodblindar Village Mira Road, Maharashtra, India – 401107.
Medleods Pharmaceuticals operates in the healthcare industry, in the medical equipment retail and distribution segment.
Medleods Pharmaceuticals can be reached at its registered office: B401 Vora Township Bldg No C S No 88111 Ghodblindar Village Mira Road, Maharashtra, India – 401107.
Medleods Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

